Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- AHPA NDI Tele-Seminar Includes Essential Guidance Documents, NDI Database Subscription Discounts
This week’s tele-seminar, Navigating FDA’s New Dietary Ingredient Notification Requirements, (May 19, 2006) will premiere the American Herbal Product Association's new Interim Guidance for New Dietary Ingredient Notifications for Manufacturers or Distributors of New Dietary Ingredients.
- AHPA NDI Tele-Seminar Includes Essential Guidance Documents, NDI Database Subscription Discounts
This week’s tele-seminar, Navigating FDA’s New Dietary Ingredient Notification Requirements, (May 19, 2006) will premiere the American Herbal Product Association's new Interim Guidance for New Dietary Ingredient Notifications for Manufacturers or Distributors of New Dietary Ingredients.
- CRN Responds To Panel Report On Multivitamins
Organization responds to the report presented by the scientific panel at the NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention held this week in Bethesda, Md.
- CRN Responds To Panel Report On Multivitamins
Organization responds to the report presented by the scientific panel at the NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention held this week in Bethesda, Md.
- European Parliament Passes Second Reading on Health and Nutrition Claims
The European Parliament has passed second reading of the Health and Nutrition Claims Regulation which will govern permitted health and nutrition claims allowable in the European Union. The regulations, incorporating compromise amendments introduced prior to this reading, are expected to be formally adopted by this autumn. The regulation includes strict conditions for nutrition claims, an initial positive list of approved health claims (after which claims submitted will have to be reviewed by the European Food Safety Authority (EFSA) and then approved by the Commission and Member States), and the use of new health claims or disease reduction claims will require specific authorization after scientific assessment and verification.
- European Parliament Passes Second Reading on Health and Nutrition Claims
The European Parliament has passed second reading of the Health and Nutrition Claims Regulation which will govern permitted health and nutrition claims allowable in the European Union. The regulations, incorporating compromise amendments introduced prior to this reading, are expected to be formally adopted by this autumn. The regulation includes strict conditions for nutrition claims, an initial positive list of approved health claims (after which claims submitted will have to be reviewed by the European Food Safety Authority (EFSA) and then approved by the Commission and Member States), and the use of new health claims or disease reduction claims will require specific authorization after scientific assessment and verification.
- European Parliament Passes Second Reading on Health and Nutrition Claims
The European Parliament has passed second reading of the Health and Nutrition Claims Regulation which will govern permitted health and nutrition claims allowable in the European Union. The regulations, incorporating compromise amendments introduced prior to this reading, are expected to be formally adopted by this autumn. The regulation includes strict conditions for nutrition claims, an initial positive list of approved health claims (after which claims submitted will have to be reviewed by the European Food Safety Authority (EFSA) and then approved by the Commission and Member States), and the use of new health claims or disease reduction claims will require specific authorization after scientific assessment and verification.
- European Parliament Passes Second Reading on Health and Nutrition Claims
The European Parliament has passed second reading of the Health and Nutrition Claims Regulation which will govern permitted health and nutrition claims allowable in the European Union. The regulations, incorporating compromise amendments introduced prior to this reading, are expected to be formally adopted by this autumn. The regulation includes strict conditions for nutrition claims, an initial positive list of approved health claims (after which claims submitted will have to be reviewed by the European Food Safety Authority (EFSA) and then approved by the Commission and Member States), and the use of new health claims or disease reduction claims will require specific authorization after scientific assessment and verification.
- European Parliament Passes Second Reading on Health and Nutrition Claims
The European Parliament has passed second reading of the Health and Nutrition Claims Regulation which will govern permitted health and nutrition claims allowable in the European Union. The regulations, incorporating compromise amendments introduced prior to this reading, are expected to be formally adopted by this autumn. The regulation includes strict conditions for nutrition claims, an initial positive list of approved health claims (after which claims submitted will have to be reviewed by the European Food Safety Authority (EFSA) and then approved by the Commission and Member States), and the use of new health claims or disease reduction claims will require specific authorization after scientific assessment and verification.
- European Parliament Passes Second Reading on Health and Nutrition Claims
The European Parliament has passed second reading of the Health and Nutrition Claims Regulation which will govern permitted health and nutrition claims allowable in the European Union. The regulations, incorporating compromise amendments introduced prior to this reading, are expected to be formally adopted by this autumn. The regulation includes strict conditions for nutrition claims, an initial positive list of approved health claims (after which claims submitted will have to be reviewed by the European Food Safety Authority (EFSA) and then approved by the Commission and Member States), and the use of new health claims or disease reduction claims will require specific authorization after scientific assessment and verification.
- European Parliament Passes Second Reading on Health and Nutrition Claims
The European Parliament has passed second reading of the Health and Nutrition Claims Regulation which will govern permitted health and nutrition claims allowable in the European Union. The regulations, incorporating compromise amendments introduced prior to this reading, are expected to be formally adopted by this autumn. The regulation includes strict conditions for nutrition claims, an initial positive list of approved health claims (after which claims submitted will have to be reviewed by the European Food Safety Authority (EFSA) and then approved by the Commission and Member States), and the use of new health claims or disease reduction claims will require specific authorization after scientific assessment and verification.
- European Parliament Passes Second Reading On Fortified Foods Regulations
The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels.
- European Parliament Passes Second Reading On Fortified Foods Regulations
The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels.
- European Parliament Passes Second Reading On Fortified Foods Regulations
The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels.
- European Parliament Passes Second Reading On Fortified Foods Regulations
The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels.
- European Parliament Passes Second Reading On Fortified Foods Regulations
The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels.
- European Parliament Passes Second Reading On Fortified Foods Regulations
The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels.
- European Parliament Passes Second Reading On Fortified Foods Regulations
The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels.
- Sageant Leads Grassroots Response to FTC Rule That Threatens Network Marketing
Sageant has launched a national grassroots campaign to secure responses to the recently proposed Federal Trade Commission (FTC) new rule on business opportunities.
- Sageant Leads Grassroots Response to FTC Rule That Threatens Network Marketing
Sageant has launched a national grassroots campaign to secure responses to the recently proposed Federal Trade Commission (FTC) new rule on business opportunities.
- NNFA Statement in Response to NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements
In response to findings by the State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention, the National Nutritional Foods Association (NNFA) maintains that multivitamins and other mineral supplements taken by more than 100 million Americans daily are a safe, affordable and effective way to maintain a healthy lifestyle.
- NNFA Statement in Response to NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements
In response to findings by the State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention, the National Nutritional Foods Association (NNFA) maintains that multivitamins and other mineral supplements taken by more than 100 million Americans daily are a safe, affordable and effective way to maintain a healthy lifestyle.
- NNFA Statement in Response to NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements
In response to findings by the State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention, the National Nutritional Foods Association (NNFA) maintains that multivitamins and other mineral supplements taken by more than 100 million Americans daily are a safe, affordable and effective way to maintain a healthy lifestyle.
- NNFA Statement in Response to NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements
In response to findings by the State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention, the National Nutritional Foods Association (NNFA) maintains that multivitamins and other mineral supplements taken by more than 100 million Americans daily are a safe, affordable and effective way to maintain a healthy lifestyle.
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- BioEnvelop Gains Registration with Health Canada for Manufacturing of Natural Health Products
Company has received a license to manufacture under the Natural Health
Products (NHP) certification program of Canada.
- BioEnvelop Gains Registration with Health Canada for Manufacturing of Natural Health Products
Company has received a license to manufacture under the Natural Health
Products (NHP) certification program of Canada.
- BioEnvelop Gains Registration with Health Canada for Manufacturing of Natural Health Products
Company has received a license to manufacture under the Natural Health
Products (NHP) certification program of Canada.
- Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods
Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods.
- Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods
Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods.
- Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods
Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods.
- Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods
Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods.
- Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods
Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods.
- Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods
Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods.
- Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods
Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods.
- FWS Restores 5-Year Minimum Age for Exported American Ginseng
The US Fish & Wildlife Service (FWS) has just announced that the export of wild American ginseng (Panax quinquefolius) roots that are at least 5 years old “will not be detrimental to the survival of the species,” and so will be allowed to be exported from states that maintain ginseng programs during the next three harvest seasons (2006–2008).
- FWS Restores 5-Year Minimum Age for Exported American Ginseng
The US Fish & Wildlife Service (FWS) has just announced that the export of wild American ginseng (Panax quinquefolius) roots that are at least 5 years old “will not be detrimental to the survival of the species,” and so will be allowed to be exported from states that maintain ginseng programs during the next three harvest seasons (2006–2008).
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- NIH Multivitamin/ Mineral Supplements Conference Report
This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
- NIH Multivitamin/ Mineral Supplements Conference Report
This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
- NIH Multivitamin/ Mineral Supplements Conference Report
This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
- NIH Multivitamin/ Mineral Supplements Conference Report
This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- CRN Applauds Senators On AER Bill Introduction
CRN commends Senators Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D-Ill.) for introducing S. 3546, “Dietary Supplement and Nonprescription Drug Consumer Act,” a bill that would require manufacturers to notify FDA of all serious adverse events (AEs) for dietary supplements and over-the-counter drugs (OTCs) reported to them.
- CRN Applauds Senators On AER Bill Introduction
CRN commends Senators Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D-Ill.) for introducing S. 3546, “Dietary Supplement and Nonprescription Drug Consumer Act,” a bill that would require manufacturers to notify FDA of all serious adverse events (AEs) for dietary supplements and over-the-counter drugs (OTCs) reported to them.
- Introduction of AER Bill in U.S. Senate Announced
A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days.
- Introduction of AER Bill in U.S. Senate Announced
A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days.
- Introduction of AER Bill in U.S. Senate Announced
A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days.
- Introduction of AER Bill in U.S. Senate Announced
A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days.
- NNFA Statement on Adverse Event Reporting Legislation
NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements.
- NNFA Statement on Adverse Event Reporting Legislation
NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements.
- NNFA Statement on Adverse Event Reporting Legislation
NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements.
- NNFA Statement on Adverse Event Reporting Legislation
NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements.
- GMP Compliance: An AHPA Tele-Seminar Series
AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Manufacturers Assured Ingredient is Safe for Use in
Functional Foods and Supplements
CEDAR RAPIDS, Iowa, May 30, 2006 - Embria Health Sciences announced today that its new high-metabolite immunogen ingredient, EpiCor (tm), has successfully achieved self-determined Generally Regarded as Safe (GRAS) status. The process involved an intense review of EpiCor's safety and toxicology data by an expert panel comprised of members with extensive Food and Drug Administration (FDA), Environmental Protection Agency (EPA) and National Institute of Health (NIH) experience.
"EpiCor's proven safety as exemplified by its supporting research and GRAS status will provide peace of mind to manufacturers," said Paul Faganel, Embria Health Sciences president and CEO, "We look forward to the positive impact we believe EpiCor will bring to the health of people worldwide."
Faganel said EpiCor is an all-natural, high-metabolite immunogen that nourishes the body's immune system to strengthen resistance and maintain wellness. It is manufactured through a proprietary, multi-stage fermentation and drying process called MetaGen4 (tm), and is safe for everyday use. EpiCor is new to the human nutrition market, although it is backed by more than 60 years of experience in animal nutrition products.
As part of the self-determination process, the expert panel was provided extensive ingredient information including the background of the ingredient, usage history, summary of anticipated daily intake and literature search. Upon completion of the material review, the panel then conducted a safety assessment. The panelists include:
---Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist. Previously with the Environmental Protection Agency (EPA) as Chief of Toxicology Branch, and with the Food and Drug Administration (FDA) as Director of Division of Drug and Environmental Toxicology.
---Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland. Formerly held positions with the FDA, EPA and National Institute of Health (NIH) and was past president of the Society of Toxicology.
---Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Previously was president of the Society of Toxicology.
EpiCor's potential for impacting the human nutrition market was discovered by accident. In early 2000, executives and employees of Embria's parent company, a leading manufacturer of animal nutrition products, realized they had filed significantly fewer health insurance claims and had unusually low sick leave rates than employees of similarly sized companies. After the company's insurance provider confirmed the employees' observations, studies were conducted to determine if the employees' unusually good health was related to their handling of the company's fermented yeast products. The results showed that those who worked directly with the company's yeast products had increased natural killer (NK) cell activity, higher antioxidant activity, a better ratio of immune helper cells to suppressor cells and lower levels of undesirable immune complexes.
The executives realized they had an ingredient with the potential to benefit millions of people around the world and soon founded Embria Health Sciences to explore the human potential of the yeast products. After extensive research, EpiCor was developed specifically for the human nutritional supplement industry.
Embria Health Sciences, www.embriahealth.com, combines science and nature to bring high-quality, research-based natural ingredients to the global human nutrition market. Headquartered in Cedar Rapids, Iowa, Embria's key products are manufactured using a proprietary technology, which produces vital metabolites that deliver nutritional benefits and support increased bioavailability. Embria Health Sciences holds "Nutrition Business Journal's" 2005 product merit awards for its selenium ingredient, eXselen (tm).
# # # |